Butterfly Learnings, a pioneering platform in pediatric behavioral and developmental health, announces the successful closure of its Series A funding, raising INR 32 crores. The Series A round is led by Insitor Impact Asia Fund II and Enzia Ventures, with participation from  CIIE (IIMA Ventures), Foundation Botnar, 9 Unicorns, and Venture Catalysts.

The infusion of funds will fuel Butterfly Learnings’ expansion efforts as it aims to scale its technology-enabled therapy programs to equip neuro-diverse children to integrate with society and manage their lives better. Currently serving approximately 2000 families across 30 centers in Maharashtra, the company plans to extend its reach across multiple states and cities in India through a 200-center network.

Karuna Jain, Partner at Enzia Ventures, said, “With this network, Butterfly will provide therapy to children across socio-economic strata but more importantly, provide access to outcomes-linked, personalized therapy to each child. Personalization of therapy and measurement of therapy outcomes is a global need. In India, this need is more pronounced with most parents only having access to speech and occupational therapists, and having no expectation setting or outcome measurement. We are already seeing strong demand across centers and only expect this to pick up more as diagnosis of developmental disorders and quality appreciation for therapy goes up.”

“In India, nearly 3 million children have autism, while one in eight (aged between 2–9) experiences at least one neurodevelopmental disorder. Unfortunately, the small number of standalone clinics currently available to parents lack a rigorous scientific approach to therapy provision. Dr. Sonam and Dr. Abhishek have successfully leveraged their extensive clinical and technological expertise to offer an evidence-based, technology-enabled therapy solution for children. We enthusiastically support them in this next phase of growth.” – Nicholas Lazos, Co-Founder and CIO at Insitor Impact Asia Fund II.

Speaking about the fundraising round and the unmet need in India for behavioral health Dr. Sonam Kothari, Co-Founder & CEO of Butterfly Learnings said, “This funding infusion will propel our mission forward, empowering us to expedite the delivery of accessible and evidence based pediatric behavioral and developmental health solutions to families across India. With our distinctive blend of technology enabled therapy delivery and focus on clinical excellence, we remain dedicated to ensuring that every child receives the support they need to thrive and grow.”

Butterfly Learnings, founded in 2021, raised $2 million in its Seed funding round from Insitor Partners, 9 Unicorns, Venture Catalysts, Fondation Botnar, UTIL Stiftung, Enzia Ventures, and CIIE.CO in 2022. The company currently operates as a comprehensive phygital platform, integrating digital and physical components to offer tailored support for children and families facing challenges related to neurodiversity. The company employs over 250 in-house trained therapists and is headquartered in Mumbai, with operations extending to urban areas such as Pune, Nagpur, and Nasik.

The platform’s core offerings include individualized therapy regimens based on Applied Behavior Analysis (ABA), consultations with skilled pediatric neurologists or developmental pediatricians, and additional therapies such as occupational therapy, speech therapy, oral placement therapy, and sensory integration.

Accredited by QABA – Qualified ABA Board and BHCOE – Behavioral Health Center of Excellence, Butterfly Learnings adheres to the highest professional practices and training standards. The company also maintains ISO 27001 certification and complies with HIPAA and GDPR to uphold data security and patient confidentiality.

Butterfly is one of the few chains in the country where pediatricians, neurologists, ABA, speech, and OT therapists come together on one platform to design, deliver, and monitor a therapy program for the child, thus ensuring better outcomes. This is also evident in its customer satisfaction – the average therapy time is 12 months, with more than 50% of kids successfully discharged from therapy and integrated into regular schools.